IP Library Granted Patent US 12,024,699
Granted Patent B2
US 12,024,699 · App. 16/735,626 · Granted Jul 2, 2024

Systems, devices, and methods for cell processing

Inventors: Farlan Singh Veraitch (London, GB); Simon Collings (Berkshire, GB); Nicholas Brown (Berkshire, GB)
Assignee: ORIBIOTECH LTD.
C12M35/04C12M21/00C12M29/00C12M35/08C12M37/04C12M41/48
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,024,699
App. No.
16/735,626
Granted
Jul 2, 2024
Kind
B2
Abstract

The disclosure relates to systems, devices and methods for at least one of cell and gene therapy manufacture. In some embodiments, a cell processing unit is provided and comprises a housing defining an enclosure into which a cell processing platform can be mounted, a platform mounting bracket within the housing and configured and arranged to receive and retain a cell processing platform, a drive apparatus configured and arranged to operatively engage and act upon a cell processing platform so as to move same with respect to the platform mounting bracket, and an actuator configured and arranged to exert a force on a container mounted into the cell processing platform so as to expel a contents from the container.

Claims (20)

1. A cell processing method configured for at least one of cell and gene therapy manufacture, the method comprising:

introducing a cell population of interest into a primary container located on and fluidly connected with a bottom of a body portion of a cell processing platform, wherein the cell processing platform is mounted within a housing of a cell processing unit, and wherein the primary container is compressible and comprises a first end, a second end arranged substantially parallel with the first end, and a wall element arranged between the first end and the second end, the wall element of the primary container being composed of a flexible material;

sequentially adding one or more reagents from one or more auxiliary containers, located on and fluidly connected with a top of the body portion with the primary container fluidly connected to the one or more auxiliary containers via the body portion and wherein the one or more auxiliary containers are compressible, to the primary container, by exerting a compression force on the one or more auxiliary containers via a first actuator within the housing of the cell processing unit, in order to effect one or more desired unit operations in cell and gene therapy manufacture;

culturing the cell population of interest in the primary container; and

exerting a force on the primary container, wherein the force comprises compression or expansion of the primary container, and wherein the force is applied via a second actuator within the housing of the cell processing unit.

2. The method of claim 1 , further comprising:

detecting at least one of a position and location of the cell processing platform.

3. The method of claim 1 , further comprising driving the cell processing platform.

4. The method of claim 3 , wherein driving comprises rotating the cell processing platform.

5. The method of claim 4 , wherein rotation is imparted on a surface of the body portion via a drive-wheel.

6. The method of claim 1 , further comprising connecting the cell processing platform with at least one other additional cell processing platform or an additional component via a sterile connector.

7. The method of claim 6 , wherein the sterile connector fluidly connects the cell processing platform with the at least one other additional cell processing platform or the additional component.

8. The method of claim 6 , wherein the sterile connector is configured to connect to a further sterile connector end.

9. The method of claim 6 , wherein the sterile connector is configured to connect to the primary container of the cell processing platform.

10. The method of claim 6 , wherein the sterile connector is a genderless sterile connector.

11. The method of claim 1 , further comprising sampling the contents of the primary container.

12. The method of claim 1 , further comprising transferring at least one gas into or out of the primary container.

13. The method of claim 1 , further comprising sealingly engaging the primary container with a second primary container.

14. The method of claim 1 , wherein the method comprises tracking at least one of a position and location of the cell processing platform.

15. The method of claim 1 , wherein the first actuator comprises a feed bellows plunger and the second actuator comprises a reactor plunger.

Assignments (2)
DEBENTURE Recorded Oct 18, 2022
From: ORIBIOTECH LTD
To: SILICON VALLEY BANK UK LIMITED
Reel/Frame 062202/0652 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2020
From: VERAITCH, FARLAN SINGH; BROWN, NICHOLAS; COLLINGS, SIMON
To: ORIBIOTECH LTD.
Reel/Frame 053916/0486 →
Priority Claims (8)
GB 1900107 · Jan 4, 2019 · national
GB 1900108 · Jan 4, 2019 · national
GB 1900109 · Jan 4, 2019 · national
GB 1900111 · Jan 4, 2019 · national
WO PCT/GB2020/005009 · Jan 3, 2020 · international
WO PCT/GB2020/050007 · Jan 3, 2020 · international
WO PCT/GB2020/050008 · Jan 3, 2020 · international
WO PCT/GB2020/050010 · Jan 3, 2020 · international
Continuity (1)
Related Publication 20200255790A1 · Aug 13, 2020